SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-19-002956
Filing Date
2019-04-12
Accepted
2019-04-12 16:02:33
Documents
6
Period of Report
2019-06-05
Effectiveness Date
2019-04-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 774355
2 GRAPHIC def14ag001.jpg GRAPHIC 4769
3 GRAPHIC def14ag002.jpg GRAPHIC 3287
4 GRAPHIC def14ag003.jpg GRAPHIC 30109
5 GRAPHIC def14ag004.gif GRAPHIC 61800
6 GRAPHIC def14ag005.gif GRAPHIC 56851
  Complete submission text file 0001558370-19-002956.txt   991935
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38150 | Film No.: 19746305
SIC: 2834 Pharmaceutical Preparations